Nevertheless, our germline analysis identified four genes with known functions likely to contribute to tumor progression and potentially drug response: FAT1 and FAT3, FAT4, and ERCC2, modeled by targeting kug, ft, and xpd, respectively. The gene discussed is ERCC2; the disease is neoplasm.